Evidence map›Paper›PMID 36210185›Full record

ArticleSurgery2023

Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19.

Reagan A Collins, Catherine DiGennaro, Toni Beninato, Rajshri M Gartland, Natalia Chaves, Jordan M Broekhuis, Lekha Reddy, Jenna Lee, Angelina Deimiller, Maeve M Alterio and 26 more

Open access · bronzeAbstract read
In one paragraph

Article in Surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 18 institutions in 3 countries.

Reagan A CollinsDepartment of Surgery, Massachusetts General Hospital, Boston, MA; Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX; Institute of Technology Assessment, Massachusetts General Hospital, Boston, MA. Electronic address: https://twitter.com/ReaganACollins.
Catherine DiGennaroInstitute of Technology Assessment, Massachusetts General Hospital, Boston, MA. Electronic address: https://twitter.com/itsdigennaro.
Toni BeninatoDepartment of Surgery, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ. Electronic address: https://twitter.com/BeninatoToni.
Rajshri M GartlandDepartment of Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: https://twitter.com/RMGartlandMD.
Natalia ChavesDepartment of Surgery, Beth Israel Deaconess Medical Center, Boston, MA. Electronic address: https://twitter.com/natalia_chaves.
Jordan M BroekhuisDepartment of Surgery, Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: https://twitter.com/j_broekhius.
Lekha ReddyDepartment of Surgery, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Jenna LeeDepartment of Surgery, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Angelina DeimillerDepartment of Surgery, MetroHealth Medical Center, Cleveland, OH.
Maeve M AlterioElson S. Floyd College of Medicine, Washington State University, Spokane, WA.
Michael J CampbellDepartment of Surgery, University of California-Davis, CA.
Yeon Joo LeeDepartment of Surgery, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.
Tyler K KhilnaniWeill Cornell Medicine/Weill Cornell Medical College, New York, NY.
Latoya A StewartColumbia University Vagelos College of Physicians and Surgeons, New York, NY.
Mollie A O'BrienDepartment of Surgery, Boston Medical Center and Boston University School of Medicine, MA.
Miguel Valdivia Y AlvaradoDepartment of Surgery, Houston Methodist, Houston, TX.
Feibi ZhengDepartment of Surgery, Baylor College of Medicine, Houston, TX.
David McAnenyDepartment of Surgery, Boston Medical Center and Boston University School of Medicine, MA.
Rachel LiouSection of Endocrine Surgery, Columbia University, New York, NY.
Catherine McManusSection of Endocrine Surgery, Columbia University, New York, NY.
Sophie Y DreamDepartment of Surgery, Medical College of Wisconsin, Milwaukee, WI.
Tracy S WangDepartment of Surgery, Medical College of Wisconsin, Milwaukee, WI. Electronic address: https://twitter.com/tracyswangNYMKE.
Tina W YenDepartment of Surgery, Medical College of Wisconsin, Milwaukee, WI.
Amal AlhefdhiDepartment of General Surgery, Breast and Endocrine Section, King Faisal Specialist Hospital and Research Centre, Al Mathar Ash Shamali, Riyadh, Saudi Arabia.
Brendan M FinnertyDepartment of Surgery, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.
Thomas J FaheyDepartment of Surgery, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.
Claire E GravesDepartment of Surgery, University of California-Davis, CA.
Amanda M LairdDepartment of Surgery, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Matthew A NehsDepartment of Surgery, Brigham and Women's Hospital, Boston, MA.
Frederick Thurston DrakeDepartment of Surgery, Boston Medical Center and Boston University School of Medicine, MA.
James A LeeSection of Endocrine Surgery, Columbia University, New York, NY. Electronic address: https://twitter.com/benjamesMD.
Christopher R McHenryDepartment of Surgery, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH.
Benjamin C JamesDepartment of Surgery, Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA.
Janice L PasiekaDepartment of Surgery, Cumming School of Medicine, University of Calgary, Alberta, Canada.
Jennifer H KuoSection of Endocrine Surgery, Columbia University, New York, NY. Electronic address: https://twitter.com/JenniferKuo5.
Carrie Cunningham LubitzDepartment of Surgery, Massachusetts General Hospital, Boston, MA; Institute of Technology Assessment, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: clubitz@mgh.harvard.edu.
Twitter (United States) · USRutgers, The State University of New Jersey · USBoston University · USColumbia University · USNewYork–Presbyterian Hospital · USMedical College of Wisconsin · USUniversity of California, Davis · USBaylor College of Medicine · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USCornell University · USHarvard University · USHouston Methodist · USKing Faisal Specialist Hospital & Research Centre · SAMetroHealth · USMetroHealth Medical Center · USUniversity of Calgary · CAWashington State University Spokane · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic profoundly impacted the delivery of care and timing of elective surgical procedures. Most endocrine-related operations were considered elective and safe to postpone, providing a unique opportunity to assess clinical outcomes under protracted treatment plans.

methodsAmerican Association of Endocrine Surgeon members were surveyed for participation. A Research Electronic Data Capture survey was developed and distributed to 27 institutions to assess the impact of COVID-19-related delays. The information collected included patient demographics, primary diagnosis, resumption of care, and assessment of disease progression by the surgeon.

resultsTwelve out of 27 institutions completed the survey (44.4%). Of 850 patients, 74.8% (636) were female; median age was 56 (interquartile range, 44-66) years. Forty percent (34) of patients had not been seen since their original surgical appointment was delayed; 86.2% (733) of patients had a delay in care with women more likely to have a delay (87.6% vs 82.2% of men, χ

conclusionAlthough some patients experienced disease progression during COVID-19 delays to endocrine disease-related care, most patients with follow-up did not. Our analysis indicated that temporary delay may be an acceptable course of action in extreme circumstances for most endocrine-related surgical disease.

Indexed as

COVID-19Endocrine System DiseasesDisease ProgressionFemaleHumansMaleMiddle AgedPandemicsSARS-CoV-2Time-to-Treatment

Identifiers

PMID36210185
PMCPMC9420726
OpenAlexW4293537601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.